The fermentation processes that are used by biopharmaceutical manufacturers have shown an increase in the number of therapeutic proteins. However, this increase in turn leads to capacity bottlenecks in the subsequent purification process (known as downstream processing) and is associated with high costs. Downstream processing comprises up to 80 percent of the entire production costs. Producers are increasingly aware of the present need for improvement and have shifted their focus from improving the production process (upstream) to improving the downstream process.https://www.creative-biolabs.com/immuno-oncology/purification-development.htm

1. Creative
-biolabs
SOLUTIONS OVERVIEW
Creative Biolabs’s expertise in bioassay and the experience gained from our
hundreds of projects have enabled us to work closely with our clients to provide
scientific and experimental expertise in the design and implementation of tailored
bioassays.
ADCC, CDC, and ADCP > Immunoassay > Immune Checkpoint Assays >
FcR Binding Assay > Tissue Cross-Reactivity Studies > Immune Cells Function Assays >
Immuno-Oncology Assay > Contamination Testing > Viral Clearance Studies >
Biosafety Testing > Protein Characterization > HCP Analysis>
Bioassays for Antibody and Protein
Creative Biolabs Confidential
4